Stephanie J. Cragg, MA, DPhil, is professor of neuroscience in the department of physiology, anatomy and genetics at the University of Oxford and a fellow of Christ Church College Oxford. She heads a research laboratory that focuses on elucidating the mechanisms that govern dopamine signaling within the basal ganglia, cells involved in motor control. Dr Cragg has identified how dopamine signaling is governed by neuromodulators, circuits and cellular and molecular mechanisms, with a focus on the role of acetylcholine, as well as dysfunction in Parkinson’s disease. Dr. Cragg and her team have technical expertise in the use of electrochemistry, electrophysiology, optical and imaging approaches and neuropharmacology to probe neuromodulatory mechanisms. Dr. Cragg is a founding investigator of the Oxford Parkinson’s Disease Centre and serves on the editorial boards for journals ACS Chemical Neuroscience and Addiction Neuroscience and the advisory board for the Dopamine Society and the college of experts for Parkinson’s UK.
Associated Grants
-
Mapping the Modulatory Landscape Governing Dopamine-acetylcholine Signaling and its Dysregulation in Parkinson’s Disease
2024
-
Mapping the Modulatory Landscape Governing Striatal Dopamine Signaling and Its Dysregulation in Parkinson’s Disease
2021
-